Alahednews
english.alahednews.com.lb
Arsal Battle: Nusra Urged to Surrender or Face Death, Battle Almost Over France Wildfires Force Mass Evacuation CIA Chief Hints Agency Is Working To Change Venezuelan Gov’t Rouhani Denounces US Sanctions: ’Will Not Go Unanswered’ Bahrain Crackdown: Tortured Rights Activist in Critical Condition, Twitter Campaign Demands Her Release Libyan Rivals Agree to Cease-Fire, Elections Saudi Is A Brutal, Extremist Dictatorship - So Why Are We Selling It Arms? US House Approves New Anti-Russia Sanctions Qatar Row: FM Says Saudi-Led Bloc of States Undermining Mediation Efforts Egypt Military Campaign: 40 Militants Killed in Sinai #Lebanon: #Hezbollah Liberates 95% of #Arsal Outskirts #Arsal Battle: #Hezbollah Raises #Lebanese Flag over Liberated Hills, Pays Tribute to Martyred Soldiers #Saudi Forces Tighten Grip on #Awamia, Neighboring Areas #Hezbollah: #Nusra Militants Regressing as Ops Head Injured #Arsal Battle: #Nusra Op. Commander Injured as Resistance Advances in the Battlefield Sayyed #Nasrallah to Deliver a Televised Speech Wednesday at 20:30 #Arsal Battle: #Islamic_Resistance Liberates 92% of #Nusra-held Areas #Lebanon Security Forces Bust #Daesh Cell Syrian Jets Raid Militants in #Lebanon - #Syria Border #Nusra Weapon Shipment Confiscated in the #SyrianDesert
Guestbook mailinglist.php arabic site french site spanish site facebook twitter rss page
News Categories » NEWS » Miscellaneous

Decrease Font Size Increase Font Size  Print Page
WHO Urges Action over Growing Hepatitis Epidemic
Local Editor

The number of people dying from hepatitis is rising, and most of the 325 million infected are unaware they have the virus and lack access to potentially life-saving medicines, the World Health Organization said Friday.

WHO Urges Action over Growing Hepatitis Epidemic

In its first global report on the infection, the WHO said that with millions at risk of a slow progression to chronic liver disease, cancer and premature death, swift action on testing and treatment was needed.

"Viral hepatitis is now a major public health challenge that requires an urgent response," the WHO's Director General Margaret Chan said in a statement.

The 325 million cases reported are of hepatitis B [HBV] or hepatitis C virus [HCV] - the main types of the five different hepatitis infections and responsible for 96 percent of deaths from the disease.

HBV infection requires lifelong treatment, for which the WHO recommends tenofovir, a generic anti-viral drug also used in HIV treatment.

Hepatitis C can be cured relatively swiftly, but the medicines are too expensive for many patients.

Pressure over pricing has been growing, notably on US manufacturer Gilead Sciences - which has developed some of the most effective treatments - and the company has taken some steps to offer discounts and provide access programs.

That includes allowing Indian drug makers to manufacture much lower-cost versions of them for sale in developing countries.

Gottfried Hirnschall, director of WHO's Department of HIV and the Global Hepatitis Program, said the WHO was working with governments, drug makers and diagnostics companies to improve access.

"More countries are making hepatitis services available for people in need - a diagnostic test costs less than $1 and the cure for hepatitis C can be below $200," he said. "But the data clearly highlight the urgency with which we must address the remaining gaps in testing and treatment."

Viral hepatitis killed 1.34 million people in 2015, a toll comparable to tuberculosis and HIV/AIDS. But while TB and AIDS deaths are falling, hepatitis deaths are on the rise and have increased by 22 percent since 2000, the WHO said.

Source: News Agencies, Edited by website team

 

21-04-2017 | 13:16


Name
E-Mail
Comment Title
Comment
Human Verification


News Coverage

Related News

Search
To Top